Welcome to TrypTAMINE Therapeutics limited

Developing the next wave of Therapeutic Solutions

Tryptamine Therapeutics Limited is pursuing Phase 2 clinical trials using its psilocybin and psilocin-based drug products for chronic pain and eating disorders.

A Precision Approach to Psychedelic Medicine

*Healthy volunteer dose ranging study in H1 2024 will support IND submissions for Phase 2a studies in patients
**The timetable is indicative only and is subject to change.